Evidence map›Paper›PMID 30882751›Full record

Trial reportMedicine and science in sports and exercise2019

Single versus Split Dose of Iron Optimizes Hemoglobin Mass Gains at 2106 m Altitude.

Rebecca Hall, Peter Peeling, Elizabeta Nemeth, Dan Bergland, Walter T P McCluskey, Trent Stellingwerff

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medicine and science in sports and exercise, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Trial
  3. Review
  4. Review
  5. Review
  6. Iron Status and Physical Performance in Athletes.Life (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Anemia in Sports: A Narrative Review.Life (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Article
  13. Review
  14. Refining Treatment Strategies for Iron Deficient Athletes.Sports medicine (Auckland, N.Z.) · 2020
    Review
  15. Article
  16. Review
  17. Review
  18. Iron considerations for the athlete: a narrative review.European journal of applied physiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Rebecca HallCanadian Sport Institute Pacific, Vancouver & Victoria, British Columbia, CANADA.
Peter PeelingSchool of Human Sciences (Exercise and Sport Science), University of Western Australia, Crawley, Western Australia, AUSTRALIA.
Elizabeta NemethDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA.
Dan BerglandHypo2 High Performance Sport Center, Flagstaff, AZ.
Walter T P McCluskeyCanadian Sport Institute Pacific, Vancouver & Victoria, British Columbia, CANADA.
Trent StellingwerffCanadian Sport Institute Pacific, Vancouver & Victoria, British Columbia, CANADA.
Canadian Sport Centre Pacific · CAFlagstaff Medical Center · USUniversity of California, Los Angeles · USUniversity of Victoria · CAUniversity of Western Australia · AU

Funding

The role of erythroferrone in iron homeostasis and in iron-loading anemiasR01DK065029 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GANZ, TOMAS · 2004 to 2017
$4.9M
Iron physiology and pathology in pregnancyR01HD096863 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEMETH, ELIZABETA · 2019 to 2023
$2.1M
NICHD NIH HHS R01 HD096863
6 · The paper itself

Abstract

purposeTo determine if a single versus a split equivalent daily dose of elemental iron was superior for hemoglobin mass (Hbmass) gains at altitude while minimizing gastrointestinal (GI) discomfort.

methodsTwenty-four elite runners attended a 3.1 ± 0.3 wk training camp (Flagstaff, AZ; 2106 m). A two-group design, randomized and stratified to baseline Hbmass, sex, and ferritin (>30 μ·L), was implemented daily as: 1) single dose of 1 × 200 mg (PM only, SINGLE) versus 2) split dose of 2 × 100 mg (AM and PM; SPLIT) elemental iron (ferrous fumarate). The Hbmass and venipuncture assessments were completed upon arrival and departure (±2 d) from camp for ferritin, hepcidin, and erythroferrone (ERFE) concentrations. Validated food frequency, GI distress, menstrual blood loss (MBL) and training questionnaires were implemented throughout. Univariate analysis was used to compare Hbmass, with baseline ferritin, dietary iron intake, MBL, and training volume used as covariates.

resultsBoth conditions increased Hbmass from baseline (P < 0.05), with SINGLE (867.3 ± 47.9 g) significantly higher than SPLIT (828.9 ± 48.9 g) (P = 0.048). The GI scores were worse in SINGLE for weeks 1 and 2 combined (SINGLE, 18.0 ± 6.7 points; SPLIT, 11.3 ± 6.9 points; P = 0.025); however, GI scores improved by week 3, resulting in no between-group differences (P = 0.335). Hepcidin significantly decreased over time (P = 0.043) in SINGLE, with a nonsignificant decrease evident in SPLIT (~22%). ERFE significantly decreased in both groups (~28.5%; P < 0.05). No between-group differences existed for ERFE, hepcidin, food frequency, MBL, or daily training outcomes (P > 0.05).

conclusionsA single nightly 200-mg dose of elemental iron was superior to a split dose for optimizing Hbmass changes at altitude in runners over an approximately 3-wk training camp.

Indexed as

AltitudeDietary SupplementsAcclimatizationAdultDrug Administration ScheduleFemaleFerritinsFerrous CompoundsGastrointestinal DiseasesHemoglobinometryHemoglobinsHepcidinsHumansMalePeptide HormonesPhysical EnduranceErfe protein, humanFerritinsFerrous Compoundsferrous fumarateHemoglobinsHepcidinsPeptide Hormones

Identifiers

PMID30882751
PMCPMC8882001
OpenAlexW2901453028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.